
I am concerned about FDA decisions to allow Mifepristone to be distributed by mail and without physician supervision.
On the public record
Every politician on the site, every statement on file. Search, filter, and read the public record.
8,500+·quotes on file

I am concerned about FDA decisions to allow Mifepristone to be distributed by mail and without physician supervision.

But given that we have both, wouldn't it be a priority to get going on it, particularly when the one we have is an older one?

But given that we have both, wouldn't it be a priority to get going on it, particularly when the one we have is an older one?

It's very important that you have transparency and certainty and particularly when we look at small businesses as well as ag producers.

I joined with 19 of my colleagues, including Senator Collins, in sending a letter to CMS expressing our dismay for the agency's coverage termination on Alzheimer's drug.

It's very important that you have transparency and certainty and particularly when we look at small businesses as well as ag producers.

But you have been directed to look at it in legislation, so the directives you get from the Congress are also of importance to you, correct?

I expressed to you at that time, you know, that we had seven commissioners in the past decade and that we need some stability in the FDA.

this would give you two, and would be in line with a directive you were given by Congress?

So I think that answer is helpful. I think it reassures people that supply is out there and that you're working on it.

Are you looking at, or will you look at Camp Grafton, because you need this facility so you can do all kind of bridges at a location other than Fort Leonard Wood.

I will certainly look at that. You all have been studying, you all have been implement or updating other Weapons Generations Facilities.

the directives you get from the Congress are also of importance to you, correct?

It's important that you have transparency and certainty and particularly when we look at small businesses.

I joined with 19 of my colleagues, including Senator Collins, in sending a letter to CMS expressing our dismay for the agency's coverage termination on Alzheimer's drug.

Thank you, both to the Chairman and the Vice Chairman. And gentlemen, thank you, for what you do for our country.

I just don't want the U.S. Government to be able to purchase it on the third party if it would require a warrant either.